European Pharmaceutical Review

JANUARY 26, 2023

These concentration measurements are used as part of regulatory decisions regarding the safety and efficacy of medicinal products. The draft ICH M10 guideline was published for comments in 2019. The post EMA publishes updated Q&A for ICH M10 appeared first on European Pharmaceutical Review.

Food and Drug Administration 87

Food and Drug Administration Medicine Pharmaceutical products Pharmaceutical 87

European Pharmaceutical Review

AUGUST 23, 2022

FAKE MEDICINES are not a new problem, and pose a tremendous threat to patient safety and public health in society regardless of a country’s economic status. 1 Simply, pharmaceutical products are the most vulnerable to counterfeiting. 1 Simply, pharmaceutical products are the most vulnerable to counterfeiting.

Medicine 90

Medicine Food and Drug Administration Pharmaceutical products Pharmaceutical 90

European Pharmaceutical Review

DECEMBER 19, 2023

25 In 2021 an estimated 25 million children under the age of one year did not receive basic vaccines, and the number of completely unvaccinated children increased by five million since 2019. 2019; 9:11409. Injection Safety Fact Sheet. 5 million lives annually for decades. Novel functions and applications of trehalose.

Distribution 99

Distribution Manufacturing Food Specialization 99

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. Regulatory body – NMPA : all pharmaceutical products sold in the Chinese market need to be granted market authorization by NMPA.

Marketing 105

Marketing Insurance Medical Manufacturing 105

European Pharmaceutical Review

AUGUST 9, 2022

According to researchers, a ribB -based colorimetric loop-mediated isothermal amplification (LAMP) assay could become a fast and easy-to-perform detection method for testing non-sterile pharmaceuticals for BCC. Burkholderia species are one of the primary causes of non-sterile pharmaceutical product recalls and accounted for 45.3

Food and Drug Administration 83

Food and Drug Administration Pharmaceutical products Pharmaceutical Pharmaceutical manufacturing 83

European Pharmaceutical Review

OCTOBER 5, 2022

However, for the pharmaceutical industry, the challenge is not as simple as just switching materials. An industry that is among the world’s biggest polluters is caught in a balancing act between satisfying the health and safety demands of industry regulators and meeting the needs of modern eco-conscious consumers.

Pharma 84

Pharma Safety Pharmaceutical Manufacturing 84

European Pharmaceutical Review

JULY 25, 2022

For pharmaceutical manufacturers, the primary solution has long been to build anti-counterfeiting technology directly into medical packaging – providing a convenient method for tracking products across supply chains as well as visual authenticity for the consumer. Supply-chain visibility. A united front.

Pharmaceutical 82

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 82